This was accompanied by a significant reduction in systemic inflammatory markers, including tumor necrosis factor α (Tnf‐α) and vascular cell adhesion molecule 1, as well as a marked attenuation of atherosclerosis.[8] Similarly, administration of Intestinimonas butyriciproducens, another butyrate‐producing bacterium, has been shown to significantly reduce body weight gain, improve hyperglycemia, decrease fat accumulation, and alleviate white adipose tissue inflammation in mice fed a high‐fat diet. The gene discussed is TNF; the disease is atherosclerosis.